Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» AXS-07
AXS-07
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
Fierce Biotech
Axsome Therapeutics
migraines
FDA
AXS-07
Flag link:
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
BioSpace
FDA
complete response letter
Junshi Biosciences
Coherus Biosciences
Axsome Therapeutics
migraines
AXS-07
Flag link:
Axsome expects migraine drug to be rejected as manufacturing issues arise
Axsome expects migraine drug to be rejected as manufacturing issues arise
Endpoints
Axsome Therapeutics
migraines
FDA
AXS-07
Flag link:
Axsome’s Migraine Drug Provides Relief in Phase III Trial
Axsome’s Migraine Drug Provides Relief in Phase III Trial
BioSpace
Axsome Therapeutics
clinical trials
AXS-07
migraines
Flag link:
Clinical developments over the Christmas period
Clinical developments over the Christmas period
EP Vantage
Google Health
Axsome
Spectrum Pharmaceuticals
Wave Life Sciences
Google DeepMind
AXS-07
WVE-120102
poziotinib
Flag link:
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
Flag link:
